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MiRNAs are key regulators of gene expression. By binding to many genes, they create a complex network of
gene co-regulation. Here, using a network-based approach, we identified miRNA hub groups by their close
connections and common targets. In one cluster containing three miRNAs, miR-612, miR-661 and
miR-940, the annotated functions of the co-regulated genes suggested a role in small GTPase signalling.
Although the threemembers of this cluster targeted the same subset of predicted genes, we showed that their
overexpression impacted cell fates differently. miR-661 demonstrated enhanced phosphorylation ofmyosin
II and an increase in cell invasion, indicating a possible oncogenic miRNA. On the contrary, miR-612 and
miR-940 inhibit phosphorylation of myosin II and cell invasion. Finally, expression profiling in human
breast tissues showed that miR-940 was consistently downregulated in breast cancer tissues
M
icroRNAs are a class of endogenous, small (19–25 nucleotides), single-stranded non-coding RNAs that
regulate gene expression in all eukaryotic organisms. Inmetazoans, microRNAsmost commonly bind to
the 39 untranslated region (39UTR) of their mRNA target transcript and cause translational repression
and/or mRNA degradation. Every microRNA is predicted to regulate from a dozen to thousands of genes,
including transcription factors. This fine-tuning of protein expression is known to be involved in many physio-
logical processes, such as development, apoptosis, signal transduction and even cancer progression1,2. More than
2,000 mature human microRNAs are listed in the 20th release of miRBase: http://www.mirbase.org (2014) (Date
of access:19/08/2013), and some authors hypothesise that the majority of human genes are regulated by
microRNAs3.
Since their discovery in 19934, a fair understanding of their role in animal development and in the onset and
progression of diseases2, as well as of their potential use in therapies5, has been gathered. However, the cooperative
behaviour of microRNAs is still under investigation. A growing body of experimental evidence suggests that
microRNAs can regulate genes through complementarity, meaning that microRNAs can act together to regulate
individual genes or groups of genes involved in similar processes6. For example, Hu and co-workers demonstrated
that transducing a cocktail of precursor microRNAs (miR-21, miR-24 and miR-221) can result in more effective
engraftment of transplanted cardiac progenitor cells7. Consistent with these discoveries, Zhu et al. demonstrated
that miR-21 and miR-221 coregulate 56 gene ontology (GO) processes8. In the same study, the authors also
showed that cotransfection of miR-1 and miR-21 increases H2O2-induced myocardial apoptosis and oxidative
stress.
These recent findings support the idea ofmicroRNA-mediated cooperative regulation but also argue for the use
of systemic approaches, notably based on graph theory, to decipher individual and complementary roles of
microRNAs. Some work has been conducted to use recent high-throughput experiment-derived data sets to
infer microRNA synergistic relationships9–12. Herein, we present a microRNA network based on target similar-
ities among microRNAs to infer clusters of microRNAs. Clusters are defined as groups of microRNAs sharing a
set of common targets, predicted by either DIANA-microT v313 or TargetScan v6.214. Some authors have usedGO
enrichment analysis as a confirmatory tool for their clustering approach11. In our case, GO enrichment is not used
to infer networks but as a way to estimate the probable metabolic pathway(s) a cluster of microRNAs could co-
regulate. Moreover, the novelty of our approach is to consider not only clusters of microRNAs but also
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‘‘microRNA hubs’’, i.e., highly connected microRNAs presenting a
crucial role in the network. We further defined these interconnected
microRNA hubs as ‘‘assorted clubs’’ of microRNAs.
This target-based microRNA network shows many similarities
with known biological networks and is constructed around two
microRNA assorted clubs. These two clubs influence the overall
shape of the network and thus the microRNAs connected to them.
One of the assorted clubs was predicted to play a role in small GTPase
signalling. Small GTPase proteins are divided in two subfamilies:
members of the Ras subfamily which regulate cell proliferation and
differentiation, and members of the Rho subfamily which control
cytoskeleton and cell motility but can also act on proliferation15.
Strikingly, all three microRNAs in the club, miR-612, miR-661,
and miR-940, efficiently downregulate small GTPase signalling.
However, their cellular function diverges showing that microRNAs
acting on similar pathways can lead to opposite outputs. Indeed,
Transwell assays and wound healing assays demonstrate that over-
expression of miR-661 leads to a dramatic increase in cell motility,
while miR-612 and miR-940 reduce this capacity. In addition, miR-
940 was found consistently downregulated in breast cancer tissues,
indicating a putative role of this microRNA in cancer progression.
Results
A target-based microRNA complementary network. To evaluate
how microRNAs could act together on cellular processes, we intended
to infer networks based on microRNA target sharing. We used the
genome-wide DIANA-microT v3.0 prediction database13, comprising
555 human microRNAs, 18,986 genes and nearly 2 million interac-
tions. We considered onlyHomo sapiens interactions and did not take
into account any score but rather used all available information. In
consequence, around 60% microRNAs are predicted to have between
2,000 and 5,000 different target sites and four microRNAs (miR-495,
miR-548c-3p, miR-590-3p and miR-603) are predicted to exhibit
affinity towards more than 10,000 target sites – which represents
around 6000 genes (Supplementary Figures S1a & S1b). Furthermore,
193 genes are targeted by more than 293 microRNAs (Supplementary
Figure S1c), which is the 99th quantile of themicroRNA-mediated target
regulation histogram. These 193 proteins will therefore be referred to
as gene (or protein) hubs9.
Following Shalgi et al.9, we built a target-based microRNA networks
based on the idea that if two microRNAs share a common set of genes,
they could act on the same pathway(s) and compensate for each other,
or act complementarily, on this pathway. Considering the DIANA-
microT v3.0 predictions, each node of the network corresponds to a
microRNA and each edge between two nodes to the proportion of
shared targets between two microRNAs (Figure 1). We used the meet/
min metric (or Simpson index) to infer the strength of the edge
between two microRNAs16,17. In our case, the meet/min index takes
into account the number of shared genes between two microRNAs,
divided by the minimum number of regulated genes between the
microRNAs. This metric takes its value between 0 and 1, where 1
implies the exact same targets, whereas 0 implies no common target.
The network thus constructed contained 555 nodes and 153,735
weighted edges with a density of 1, meaning that all nodes in the
network are interconnected with different strengths.
Many algorithms have been implemented in systems biology to
analyse weighted graphs, notably in protein-protein interaction (PPI)
networks. Some algorithms are based on maximal cliques finding and
ranking. Although algorithms based on this method are NP-hard, it
is not a problem in PPI networks due to their sparse properties18.
However these methods are not suited to our network which is
highly dense. As a consequence, and in spite of information loss,
the weighted graph was simplified into a binary graph by defining a
meet/min threshold through a ‘‘multiple-thresholds-approach’’19,20,
which consists of the comparison of different thresholded networks.
To define an appropriate threshold, we analysed changes in the
network properties for different meet/min thresholds. Density and
clustering coefficients are common properties used in this sense21.
The density measures the number of edges compared to the number
of awaited edges if every node were connected in the network. In
addition to the number of edges and connected nodes in the graphs,
we also considered different centrality measurements such as between-
ness and degree centrality22. Our aim was to keep the maximum
number of connected nodes in the graph but still be able to analyse it.
Figure 1 | Construction of the microRNA network. The meet/min metric measures target coverage between microRNAs. A threshold (0.5 is chosen
throughout the article) is imposed on the meet/min edges, thus defining a binary network of microRNAs that share common targets. #: number of.
www.nature.com/scientificreports
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Every node is connected to at least one neighbour in the graph
until meet/min reaches 0.48, at which point the number of edges
decreases sharply (Supplementary Figure S1d). At meet/min 0.4,
the density is close to 0 (Supplementary Figure S1e), meaning that
the graph is sparse (scattered nodes that are not highly connected to
each other), in contrast to the weighted one. The global clustering
coefficient gives the degree to which nodes in a graph tend to form
clusters (or to put it more simply: the number of ‘‘triangles’’ in the
network). The clustering coefficient reaches its minimum near meet/
min 0.5 (Supplementary Figure S1e). Finally, centrality measure-
ments evaluate the centrality of each node within the network.
Betweenness centrality gives for a given node the number of shortest
paths from all pairs of nodes that pass through this node, whereas
degree centrality gives information on the degree of this node, that
is, the number of edges linked to the node. Node-level centrality
measurements can additionally be averaged into single graph-level
scores. In our case, the two graph-level centrality measurements are
high at this 0.5 meet/min threshold (Supplementary Figure S1e
and Supplementary Table I). Furthermore, the network contains
555 nodes and 2,911 edges with a density of 0.02 (Figure 2a).
Increasing the threshold further leads to networks formed of isolated
modules where onlymicroRNA families can be found (let-7,miR-17/
miR-93 cluster, etc.) and whose seed sequences are almost identical
in each cluster.
To fully appreciate centralities, we compared 3 graphs for 3 dif-
ferent meet/min thresholds (0.25, 0.5, 0.75) to a random network
with 555 nodes and 2,911 edges23, a scale-free graph iterative con-
struction with 555 nodes24 and a human PPI based on the yeast two-
hybrid system25 (Supplementary Table I). The density of the human
interactome graph ismuch lower than the other graphs except for the
meet/min 0.75 and meet/min 1 graphs, where only microRNA fam-
ilies are found (e.g., the let-7 family). The centrality measurements of
the meet/min 0.5 graph are in general much higher than every other
graph – as is the clustering coefficient – showing an underlying
organization of the meet/min 0.5 network based on hubs and closely
linked groups of microRNAs. With a diameter (longest of the short-
est paths between any two nodes) of 5 and an average path length
(average shortest path between all possible pairs of nodes) of 2.5, the
meet/min 0.5 graph is a rather compact graph (Figure 2a and
Supplementary Table I). We thus set the meet/min threshold to 0.5
as follows: imposing the condition that two microRNAs are con-
nected in the graph only if they share 50% of their targets. Under
this condition, the graph shows a slight scale-free behaviour (R2 5
0.64), is formed of modules and is dissassortative (Supplementary
Figure S2) – a dissassortative network being a network where low
degree nodes tend to connect more often to higher degree nodes. It
also tends to be a small-world network with high centrality measure-
ments where information is easily transmitted from one node to
another, and with central hubs coordinating information. Small-
world networks are typical networks where nodes are not all con-
nected to others but are easily reachable through other common
nodes. Interestingly, it is at this threshold that we observed these
specific characteristics, which are in concordance with our current
understanding of biological networks26. Although threshold choice is
always subjective, we compensated for this arbitrary factor by apply-
ing an exploratory statistical analysis to the whole graph.
Deciphering ‘‘assorted clubs’’ of microRNAs. Baraba´si and Oltvai
defined ‘‘modules (or clusters)’’ as highly interconnected groups of
nodes21. In our model, a cluster comprises interconnected microRNAs
that all share a high number of targets.
To test and decipher the underlying organization based on prev-
iously described hubs, we followed a ‘‘rich-club strategy’’27. According
to the authors, a rich club can be defined as interconnected hubs in a
Figure 2 | DIANA-microT network atmeet/min 0.5. (a)The network can be divided into two parts (pink and cyan) linked by a few commonmicroRNAs
in the middle (purple). In cyan are the nodes that are connected to at least one microRNA of the assorted club 1; in pink are the nodes connected to
the assorted club 2; and in purple are the nodes connected to both groups. The nodes not directly connected to the assorted clubs are in grey. Four nodes
remained isolated from the entire graph; they are shown in the top left part. Node size is proportional to the node degree. (b) Assorted club 1 has a
density of 0.8. It comprises miR-495, miR-548c-3p, miR-590-3p, miR-186, miR-579, miR-513a-3p, miR-543 and miR-944. (c) The assorted club 2 has a
density of 1 and is composed of miR-661, miR-612 and miR-940.
www.nature.com/scientificreports
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network with a density of 1 (clique), i.e., a group with a central and
influential role. In our case, as the density is high but below 1, we
chose to name the groups ‘‘assorted clubs’’ referring to the assortative
behaviour of these interconnected and central microRNAs. The ana-
lysis of the density formed by the induced subgraph of the i first nodes
of highest degree (that is, the hubs sorted by their degree) reveals the
presence of two assorted clubs (Supplementary Figure S3). At 11
hubs, the first assorted club (assorted club 1) is formed by 8
microRNAs with density of 0.8 and is further emphasised in blue
in Figure 2a and b. The second assorted club (assorted club 2) is
formed by 3 microRNAs (shown in red in Figure 2a and c) with a
density of 1. Knowing that the graph global density is 0.02, the high
density values highlight the close connectivity between the different
microRNAs and, more interestingly, the high number of shared tar-
gets between all of them. Their close connections further reinforce the
idea of a common co-regulated biological process between the differ-
ent microRNAs. As the 12th microRNA is neither connected to the
first assorted club nor to the second, we decided to define two clubs
with the first 11 degree hubs of the network (Figures 2b and 2c). The
two clubs are regrouped into one single network with the 48th
microRNA (Supplementary Figure S3).
Despite the normalization imposed by the meet/min formulae,
there is still a correlation between the number of potential targets of
a microRNA and its number of neighbours in the network (Supple-
mentary Figure S4). Thus, the hubs are not only the microRNAs that
are highly connected to other microRNAs but also those with the
highest number of predicted targets. Interestingly, most of the hubs
also have a high node-level betweenness centrality value (ranging from
0.40 to 0.67). Seven out of the 11 hubs presented here can also be
found within the 13 first betweenness centrality sorted nodes. These
7 microRNAs (the 3 microRNAs from the assorted club 2 and 4
from the assorted club 1, namely miR-495, miR-548c-3p, miR-590-
3p and miR-186) also seem to be placed at key central positions in
the network, defining two separate zones (Figure 2a). The other
4 microRNAs are the remaining members of the assorted club 1.
They are, however, more offset on the graph, explaining their lower
betweenness centrality values.
To further visualise the structure of the graph organised around
the central hubs, we color-coded in cyan the microRNAs linked to at
least one of the members of the assorted club 1, in pink the neigh-
bours of at least one of the members of club 2, and in purple the
microRNAs connected to at least one member of each cluster
(Figure 2a). With this colour scheme, we clearly see that there are
three parts structured around the two assorted clubs. The purple part
delineates a trench between the two clubs (intermediate zone) that
are central to the two extreme zones (cyan and pink).We thus named
the two extreme zones as the ‘‘sphere of influence’’ of the assorted
clubs. This general organization explains the high graph-level cent-
rality measurements that we observe across the network.
Assorted club 1. The assorted club 1 is composed of 8 microRNAs
(Supplementary Table II), including the microRNA with the highest
degree in the graph (miR-495). The latter is connected to 72% of the
miRNome – hereby defined as the 555 microRNAs of DIANA-
microT v3. miR-495 is also predicted to target 6,626 different genes
and has 13,900 different target sites. On average, the microRNAs of
this group target approximately 5,000 genes. As many as 5,276 genes
are shared by at least 4 microRNAs (50%) of the cluster, and 540
genes are shared by all 8 microRNAs. Within this club, only miR-495
and miR-543 are clustered on the genome. They are both localised on
chromosome 14 and separated by approximately 1,500 base pairs
(Supplementary Figure S5).
As this cluster is composed of hubs of the highest degree in the
network and because there is a correlation between the number of
targets and the number of edges for a microRNA, one would expect
this group to have low specificity. This can be explained by the fact
that microRNA hubsmay have to regulate a large number of genes at
the same time. Indeed, we can suppose that themore genes a group of
microRNAs has to regulate, the less specificity it will have – as other
groups regulating a part of those genes would bring redundancy. As
such, within the 540 genes shared by all 8 microRNAs, 17% of shared
genes of this cluster are gene hubs. This represents 47% of all protein
hubs (Supplementary Figure S6a - Fisher exact test P-value5 10290).
To further interpret the role of microRNA clusters, we looked at
the enrichment of gene ontology (GO)28 for the coregulated genes of
each cluster. A Benjamini-Hochberg (BH) correction was used to
account for multiple testing hypothesis correction29, even though
we did not consider the corrected P-values as pure decision-making
values (see theMethods section for a brief discussion). Only the genes
that were shared by at least 50% of all members of the clusters were
used in this analysis (4 microRNAs). Using the package TopGO30 to
calculate the GO enrichment, we found enrichment in mRNA
processing, transcription and gene expression on the biological pro-
cess (BP) level of GO (Table 1: assorted club 1), for which BH cor-
rected P-values (PBH) ranged from 1025 to 1028. When considering
less generic annotations, we found enrichment for protein modifica-
tion (PBH5 33 1024), endosomal transport (PBH5 53 1024) and
regulation of locomotion (PBH 5 1022). Consistent with these
findings, ‘‘nucleus’’ was found as the localization of a significantly
high number of genes targeted by the microRNAs (PBH 5 1.6 3
1027) (Supplementary Table III. Cellular Component). Accord-
ingly, metal ion binding (PBH 5 6.3 3 10210) was found in the
molecular function (MF) category (Supplementary Table III. Mole-
cular Function). Although they are very general annotations, the
results correlate with DNA/RNA binding and mRNA processing,
showing that the cluster seems to regulate transcription regulators.
Unfortunately, a literature review of the 8microRNAs reveals little
information on their cooperative behaviour and their role in the
regulation of transcription factors. However, miR-186 and miR-
543 are both cited by different studies in cellular aging31,32, dem-
onstrating the possibility of their coaction. miR-495 and miR-543
were both identified – with other microRNAs – as actors in the
epithelial to mesenchymal transition (EMT)33. miR-495 is known
to have an effect on cell differentiation and proliferation34–36 and is
also known to be a tumour suppressor37. AlthoughmiR-186 is known
to have an effect on a proapoptotic purinergic receptor38, it is not
known whether this microRNA has a direct role on apoptosis.
Similarly, miR-590-3p has a role in neuronal death39, whereas
miR-513a-3p is known to be involved in the immune system res-
ponse mediated by interferon gamma (IFN-c)40. Finally, miR-548c-
3p is involved in the DNA repair process by acting on TOP2A
translation41. Based on existing knowledge of the biological role of
the microRNAs in question, it is difficult to draw conclusions about
their complementary behaviour.
Nonetheless, the positions of themembers of this assorted club are
central to the graph, especially for miR-548c-3p, miR-590-3p, and
miR-495 (Figure 2b). By their neighbourhood positioning, they
clearly definewhat we have called a ‘‘sphere of influence’’ represented
in cyan in Figure 2a. To understand the biological role of this sphere,
we also looked at the GO enrichment using the genes that were
shared by 25% of the 315 microRNAs (Table 1: sphere of influence
club I and Supplementary Table IV). As most of the coregulated
genes of the assorted club and its sphere of influence are shared
(Supplementary Figure S6c), one could a priori anticipate an enrich-
ment correlation between the two. The sphere appears to be involved
not only in transcription regulation – just as the assorted club is itself
– but also in development and differentiation (PBH ranging from1024
to 1027). This further demonstrates how the hubs influence the other
microRNAs around them. By further restricting the genes used for
the enrichment calculation to target genes shared by at least 50% of
the 315microRNAs, we saw a clear focus of the ontology on ‘‘nervous
system development’’ (Supplementary Table V). This statement can
www.nature.com/scientificreports
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be explained by the protein hubs introduced earlier. The ontology
enrichment of the 193 protein hubs from DIANA-microT shows the
same focus on ‘‘nervous system development’’ (Supplementary Table
VI). As the limitation imposed for the second enrichment calculation
on the sphere (genes shared by 50% of the microRNAs) includes
many of the protein hubs (Supplementary Figure S6e), it biases the
result of the enrichment toward nervous development processes.
Assorted club 2. Assorted club 2 is composed of 3 microRNAs
(Supplementary Table IV), namely miR-940, miR-661 and miR-612.
On average, each microRNA of this cluster is predicted to target 5,254
genes. A total of 4,596 genes are predicted to be regulated by at least
2 microRNAs of the cluster, defining the consensus set of genes
used for the GO enrichment. The three microRNAs are localised on
three different chromosomes. miR-940 is located on chromosome 16,
miR-661 on chromosome 8, and miR-612 on chromosome 11
(Supplementary Figure S5). This second assorted club should exhibit
more specificity than the first, as the microRNAs target fewer mRNAs
on average than the assorted club 1 microRNAs. Within the 1,830
genes that are shared by all three microRNAs, approximately 6.5% are
protein hubs. This represents more than 61% of the DIANA-microT
protein hubs (Supplementary Figure S6b - Fisher exact test P-value5
10271). Fifty-two protein hubs are shared between the assorted club 1
and this club.
‘‘Small GTPase-mediated signal transduction’’ was the most
enriched GO term at the level of BP (PBH 5 5 3 1023), followed
by terms involved in cell communication and signalling (PBH, 0.05)
(Table 2: assorted club 2). A significant number of proteins targeted
by this cluster are localised in the membrane (cell membrane, organ-
elle membrane, plasma membrane, etc.) and cell junction (PBH ,
1025) (Supplementary Table VII: Cellular Component). Finally, we
found enrichment in phospholipid binding (BH corrected P-value5
0.036) when looking at molecular functions (Supplementary Table
VII: Molecular Function). No other term passed our statistical cri-
teria, even though small GTPase regulation and binding (‘‘Ras
GTPase binding’’, ‘‘Rho guanyl-nucleotide exchange factor activity’’)
Table 1 | Gene Ontology enrichment of the assorted club 1 and its sphere of influence (biological process). Only the 20th first terms of each
list are represented. In green are represented the terms related to nervous system development, a bias induced by the protein hubs
Assorted club I (5,276 genes shared by 50% of the microRNAs – at least 4 microRNAs/8)
GO.ID Term Annotated Significant classicFisher BH.pval
GO:2000112 regulation of cellular macromolecule biosynthetic process 2817 989 7.50E-12 3.08E-08
GO:0019219 regulation of nucleobase-containing compound metabolic process 3046 1058 2.10E-11 4.31E-08
GO:0031326 regulation of cellular biosynthetic process 2998 1040 5.00E-11 6.85E-08
GO:0010556 regulation of macromolecule biosynthetic process 2877 1000 8.50E-11 8.73E-08
GO:0051252 regulation of RNA metabolic process 2674 935 1.10E-10 9.04E-08
GO:0009889 regulation of biosynthetic process 3026 1045 1.50E-10 1.03E-07
GO:0051171 regulation of nitrogen compound metabolic process 3121 1074 1.90E-10 1.12E-07
GO:0006355 regulation of transcription. DNA-dependent 2602 909 2.80E-10 1.44E-07
GO:0010468 regulation of gene expression 3004 1035 3.60E-10 1.64E-07
GO:2001141 regulation of RNA biosynthetic process 2618 912 5.10E-10 2.10E-07
GO:0006351 transcription. DNA-dependent 2847 980 1.70E-09 6.35E-07
GO:0031323 regulation of cellular metabolic process 3967 1322 9.20E-09 3.15E-06
GO:0034645 cellular macromolecule biosynthetic process 3685 1231 2.40E-08 7.59E-06
GO:0009059 macromolecule biosynthetic process 3756 1251 3.70E-08 1.09E-05
GO:0032774 RNA biosynthetic process 2909 984 9.50E-08 2.60E-05
GO:0019222 regulation of metabolic process 4375 1435 1.40E-07 3.60E-05
GO:0060255 regulation of macromolecule metabolic process 3757 1245 1.50E-07 3.63E-05
GO:0080090 regulation of primary metabolic process 3884 1283 2.00E-07 4.57E-05
GO:0070647 protein modification by small protein conjugation or removal 612 240 2.80E-07 6.06E-05
GO:0044249 cellular biosynthetic process 4466 1453 1.10E-06 2.26E-04
Sphere of influence Club I (4,208 genes shared by 25% of the microRNAs – at least 79 microRNAs/315)
GO.ID Term Annotated Significant classicFisher BH.pval
GO:0007399 nervous system development 1539 472 8.10E-11 3.33E-07
GO:2000112 regulation of cellular macromolecule biosynthetic process 2817 790 7.70E-09 1.58E-05
GO:0010556 regulation of macromolecule biosynthetic process 2877 799 4.20E-08 4.81E-05
GO:0019219 regulation of nucleobase-containing compound metabolic process 3046 840 6.50E-08 4.81E-05
GO:0031323 regulation of cellular metabolic process 3967 1069 7.80E-08 4.81E-05
GO:0048869 cellular developmental process 2496 700 8.10E-08 4.81E-05
GO:0031326 regulation of cellular biosynthetic process 2998 827 8.20E-08 4.81E-05
GO:0009889 regulation of biosynthetic process 3026 832 1.40E-07 6.99E-05
GO:0023052 signaling 4226 1130 1.60E-07 6.99E-05
GO:0035556 intracellular signal transduction 1716 497 1.70E-07 6.99E-05
GO:0030154 cell differentiation 2348 657 3.40E-07 1.20E-04
GO:0007154 cell communication 4338 1154 3.50E-07 1.20E-04
GO:0000902 cell morphogenesis 843 263 4.20E-07 1.33E-04
GO:0006351 transcription. DNA-dependent 2847 782 4.80E-07 1.36E-04
GO:0006355 regulation of transcription. DNA-dependent 2602 720 5.00E-07 1.36E-04
GO:0051252 regulation of RNA metabolic process 2674 738 5.30E-07 1.36E-04
GO:0032502 developmental process 3958 1058 5.90E-07 1.42E-04
GO:0007167 enzyme linked receptor protein signaling pathway 784 246 6.20E-07 1.42E-04
GO:2001141 regulation of RNA biosynthetic process 2618 723 6.60E-07 1.42E-04
GO:0009653 anatomical structure morphogenesis 1827 521 6.90E-07 1.42E-04
www.nature.com/scientificreports
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were also found in the list at less significant P-values, confirming the
first enrichment described above. Following this clear enrichment in
small GTPase signalling, we also found enrichment in cell organiza-
tion and cellular development, but with higher corrected and uncor-
rected P-values (, 0.001 and, 0.3, respectively). Overall, there was
a consistency in enriched GO terms around GTPase signalling, even
though P-values were not strikingly significant.
To confirm the prediction regarding this cluster, we looked at the
localization and quantified the level of phosphorylated myosin light
chain II (MLCII) in Retinal Pigment Epithelial (RPE1) cells using
phospho-myosin light chain II antibodies. MLCII is a substrate of
Rho-associated protein kinases (ROCK) but is also an ideal readout
to monitor small GTPase signalling, as it is the end product of this
signalling cascade42. Additionally, the cells were plated on micropat-
terned fibronectin to normalise their shape and actin cytoskeleton
architecture, which was also monitored via phalloidin distribution43.
Figure 3a shows RPE1 cells treated by siRNA-AllStars (negative con-
trol) and Y27632, a chemical inhibitor of ROCK used as a positive
control, on 500 mm2 circular fibronectine patterns. A decrease in the
global phosphorylation of MLCII was observed with Y27632.
However, as the patterns were small compared to the size of RPE1
cells, RPE1 cells were constricted, which involved less cellular con-
traction. 1000 mm2 circular fibronectine patterns were used in the
following experiments so that cells had fewer restrictions and also so
that a generally higher level of phosphorylation could be observed.
The quantification of MLCII phosphorylation by Western blot on
unrestricted cells showed a decrease in phosphorylation with each
human microRNA mimic in comparison to the siAllStars negative
control (Figure 3b), which confirmed the involvement of the three
microRNAs in small GTPase signalling. Furthermore, Figure 3c
shows that upon transfection of miR-612 and miR-940 mimics, the
cells were relaxed and exhibited the same behaviour as the cells
treated with Y27632. Their actin filaments were disorganised, with
an absence of stress fibres and transverse arcs compared to cells
treated with siRNA-AllStars (Figure 3c). In contrast, the miR-661
mimic revealed a higher number of myosin-decorated stress fibres
Table 2 | Gene Ontology enrichment of the assorted club 2 and its sphere of influence (biological process). Only the 20th first terms of each
list are represented. In green are represented the terms related to nervous system development, a bias induced by the protein hubs
Assorted Club II (4,596 genes shared by 50% of the microRNAs – at least 2 microRNAs/3)
GO.ID Term Annotated Significant classicFisher BH.pval
GO:0007264 small GTPase mediated signal transduction 575 186 2.40E-06 5.67E-03
GO:0007154 cell communication 4338 1148 3.00E-06 5.67E-03
GO:0023051 regulation of signaling 1778 503 5.00E-06 5.67E-03
GO:0009966 regulation of signal transduction 1553 444 6.20E-06 5.67E-03
GO:0007399 nervous system development 1539 440 6.90E-06 5.67E-03
GO:0035556 intracellular signal transduction 1716 484 1.10E-05 6.68E-03
GO:0023052 signaling 4226 1113 1.30E-05 6.68E-03
GO:0048583 regulation of response to stimulus 2027 563 1.30E-05 6.68E-03
GO:0007265 Ras protein signal transduction 353 118 3.40E-05 1.55E-02
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway 581 180 5.70E-05 2.34E-02
GO:0016192 vesicle-mediated transport 858 254 6.50E-05 2.43E-02
GO:0007165 signal transduction 3789 994 1.00E-04 3.42E-02
GO:0048011 nerve growth factor receptor signaling pathway 219 77 1.30E-04 4.11E-02
GO:0006897 endocytosis 335 110 1.40E-04 4.11E-02
GO:0010646 regulation of cell communication 1317 371 1.50E-04 4.11E-02
GO:0051056 regulation of small GTPase mediated signal transduction 336 110 1.60E-04 4.11E-02
GO:0035725 sodium ion transmembrane transport 16 11 1.90E-04 4.59E-02
GO:0009653 anatomical structure morphogenesis 1827 499 2.70E-04 6.16E-02
GO:0051179 localization 3782 986 3.00E-04 6.49E-02
GO:0007167 enzyme linked receptor protein signaling pathway 784 229 3.50E-04 7.04E-02
Sphere of Influence Club II (3,605 genes shared by 25% of the microRNAs – at least 33 microRNAs/129)
GO.ID Term Annotated Significant classicFisher BH.pval
GO:0007154 cell communication 4338 1020 1.40E-18 5.75E-15
GO:0023052 signaling 4226 986 1.30E-16 2.67E-13
GO:0007399 nervous system development 1539 406 1.10E-13 1.51E-10
GO:0023051 regulation of signaling 1778 455 5.30E-13 5.44E-10
GO:0007268 synaptic transmission 574 176 1.10E-11 9.04E-09
GO:0035637 multicellular organismal signaling 652 193 3.30E-11 2.26E-08
GO:0007165 signal transduction 3789 860 7.50E-11 4.40E-08
GO:0007264 small GTPase mediated signal transduction 575 173 9.00E-11 4.57E-08
GO:0009966 regulation of signal transduction 1553 394 1.00E-10 4.57E-08
GO:0019226 transmission of nerve impulse 644 189 1.20E-10 4.93E-08
GO:0007265 Ras protein signal transduction 353 117 2.10E-10 7.84E-08
GO:0048666 neuron development 714 204 2.80E-10 9.59E-08
GO:0022008 neurogenesis 1010 271 4.10E-10 1.30E-07
GO:0035556 intracellular signal transduction 1716 425 5.40E-10 1.58E-07
GO:0048856 anatomical structure development 3476 789 8.30E-10 2.27E-07
GO:0030030 cell projection organization 822 226 1.40E-09 3.60E-07
GO:0030182 neuron differentiation 876 238 1.60E-09 3.87E-07
GO:0007409 axonogenesis 479 145 2.00E-09 4.57E-07
GO:0048699 generation of neurons 952 254 2.80E-09 5.96E-07
GO:0048731 system development 3014 691 2.90E-09 5.96E-07
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Figure 3 | Involvement ofmiR-661, miR-612 andmiR-940 in small GTPase signalling. (a) Immunostaining of phosphomyosin II and actin filaments of
RPE1 cells plated on 500 mm2 circular fibronectin patterns. RPE1 cells were transfected with siRNA-AllStars (siAllStars, negative control) and Y27632
(ROCK inhibitor). They were immunolabeled for phosphomyosin II. Nine different images for each condition were taken, aligned and projected into a
single image by using the median value of all images for each pixel (Median Z projection of ImageJ). Rescaled with the same conditions, the images
were color-coded with the ‘‘fire’’ look-up table to highlight intensity variations. Scale bar, 5 mm. (b) Western blot of phosphomyosin II. RPE1 cells were
lysed and supplemented with protease inhibitor. A total of 10 mg of proteins were deposited and hybridised to MLCII antibodies. GAPDH was used
as a loading control. The bar plot shows the GAPDH-normalised signal rescaled to siAllStars. (c) Immunostaining of phosphomyosin II and actin
filaments. RPE1 cells were transfected with miR-612, miR-661 or miR-940 mimics and immunolabeled for phosphomyosin II and actin fibres on
1000 mm2 circular fibronectin patterns. For myosin and actin images, 9 to 12 images were taken, aligned and projected into a single image. They were
color-coded with the ‘‘fire’’ and ‘‘green hot’’ look-up table to highlight intensity variations for myosin and actin staining, respectively. Scale bar, 5 mm.
(d) Log10 of phosphorylatedmyosin II fluorescence intensity. The integrated fluorescence intensity of myosin was calculated from single images after cell
segmentation for each condition. P-values were calculated using the non-parametric two-sided Mann-Whitney test and the number of observations
(n) for this calculation. a.u.: arbitrary units. (e) Log10 of actin fluorescence intensity. The integrated fluorescence intensity of actin filaments was
calculated from single images after cell segmentation for each condition. P-values are calculated using the non-parametric two sided Mann-Whitney test
and the number of observations (n) for this calculation. a.u.: arbitrary units.
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and highly contracted cells with dense fibres (Figure 3c). However,
we clearly observed that miR-661 induced a spatial reorganization
of MLCII from the border of the cells to the entire cell surface. With
an image-based phosphorylation quantification, we observed that
the overall phosphorylation level of MLCII was only significantly
reduced with the overexpression of miR-612 and miR-940 (P-values
5 0.04 and 1.23 1025, respectively) (Figure 3d). Finally, an increase
in actin filament staining was observed in RPE1 cells treated with
miR-661 (P-value 5 0.012, Figure 3e). In contrast, there was a
decrease in actin staining following miR-612 andmiR-940 treatment
(P-values 5 0.031 and 1.23 1025, respectively).
A transwell assay and a wound healing assay were carried out to
investigate the influence of the three microRNAs on the cytoskeleton
dynamics and the ability of the cells to modify their shape and
migrate. The aim of the transwell assay was to capture the dynamics
of the cell cytoskeleton and the ability of cells to migrate through
holes whereas the wound healing assay determined the ability of the
cells to divide and migrate. miR-661 clearly produced an increase in
the number of cells that went through the transwell membrane com-
pared to the control (Figure 4a, P-value 5 1.3 3 1028, Mann-
Whitney test). In the same manner, miR-661 allowed the cells to
close the wound faster compared to the control (Figure 4b) but also
more constricted cells with increased actin staining (Figure 4c). These
two results show that miR-661 greatly enhances cell motility and
division when overexpressed. Conversely, miR-612 produced a sig-
nificant decrease in the number of cells crossing the transwell mem-
brane (P-value 5 4.9 3 10236, Mann-Whitney test) and completely
blocked the closure of the wound. The microRNA also induces
changes in the general shape of the cells and their interaction with
each other. Indeed, the cells are less constricted and form a hollow
network resembling epithelium surface (Figure 4c). In the same way,
miR-940 also produced a decrease in the number of cells (P-value5 6
3 1028, Mann-Whitney test) but to a lesser extent, and exhibited no
clear difference overall on the wound healing assay compared to the
control. However, the impact of the microRNA overexpression on the
shape of the cells is still highly visible and follows the same trend as
miR-612 with, again, a less marked phenotype (Figure 4c). These
results strongly support our ontology prediction with respect to the
assorted club 2 and our previous observations from the micropat-
terned assay where strong effects on cell motility and the cytoskeleton
organization was observed.
To assess the regulation power of the networkmicroRNA, we then
colour-coded the network according to microRNA expression in 8
different normal tissues (notably breast, colorectal mucosa, lung,
prostate, blood, prefrontal cortex, liver and muscle). Interestingly,
miR-940 is moderately to highly expressed (pink to red node) in 7
tissues out of 8 whereas miR-661 and miR-612 both show little or no
expression (white node) in the same tissues. On the other hand, only
miR-612 is expressed in normal colorectal mucosa (Supplementary
Figure S7 and S8). The threemicroRNAs seem rarely co-expressed in
the different tested tissues. This is consistent with the phenotypic
outputs that we observed after ectopic overexpression of these
microRNAs in RPE1 cells.
Differential expressions of the three microRNAs between healthy
and cancerous tissues were then carried out on Gene Expression
Omnibus (GEO) data. Interestingly, miR-940 was found consistently
downregulated in breast cancer (log fold change of 20.26 on
GSE44124, -0.53 on GSE31309, and -0.57 on GSE38867). Moreover,
two out of the three datasets tested showed a statistically very signifi-
cant differential expression (Figure 5). These data are consistent with
our previous results on the role of miR-940 in cell dynamics andmight
shed light on a probable role of this microRNA in breast cancer
progression.
Just as with assorted club 1, the members of assorted club 2 also
define their own sphere of influence. This sphere is composed of 129
microRNAs (pink in Figure 2a). With a limitation to the 4,208 genes
shared by 25% of the sphere microRNAs (at least 33 microRNAs),
there is enrichment mostly for ‘‘signalization’’ but also for ‘‘nervous
system development’’. The corrected P-values range from 1026 to
10214 (Table 2: sphere of influence Club 2 and Supplementary
Table VIII). The annotations again follow the same trend as the
enrichment of the assorted club 2 due to the high number of shared
targets (Supplementary Figure S6d). With genes shared by at least
50% of the 129 microRNAs, a higher bias toward nervous system
development is observed (Supplementary Table IX). In both cases,
the enrichment for brain development can be explained by the pro-
tein hubs shared by the microRNAs of the sphere (Supplementary
Figure S6f).
The transitory zone of influence (purple on Figure 2) is not highly
enriched for any particular process (Supplementary Table X and XI).
Indeed, the enrichment of the 3,011 genes shared by at least 25% of
the transitory zone (23 microRNAs on 89) is enriched mainly for
‘‘transport’’ with BH corrected P-values ranging from 1021 to 1024 (9
first annotations in BP). For genes shared by at least 50% the
microRNAs of this zone, no enrichment could be found. So, in gen-
eral and reassuringly, no clear enrichment is found for the group of
microRNAs that are connected to both assorted clubs.
Robustness of the approach. To assess the robustness of our
approach, we compared the results obtained using DIANA-microT
v3 to those from TargetScan v6.2 (June 2012)44, a prediction tool also
based on seed sequence analysis. We chose to limit this study to the
non-conserved version of the TargetScan algorithm, as no real proof
indicates that targets which are conserved across species are more
accurate than non-conserved targets45, and also to reduce the
number of false negative prediction. Due to the differences in the
prediction algorithms, the two databases predict differentmicroRNA
targets. These differences in target prediction are further illustrated
in Supplementary Figure S9, where we observe that the coverage
of microRNA targets between the two databases is – on average –
only approximately 60% (meet/min, Supplementary Figure S9). The
coverage is slightly higher when considering only the members of the
assorted clubs but is still below 70%. The most covered microRNA is
miR-513a-3p, with a meet/min value of 84%, whereas the least covered
microRNA is miR-543, with a meet/min value of 59% (Supplementary
Figure S9a).
Despite the differences in target prediction, the TargetScan network
built with the same process described above has a similar two-part
structure to that obtained using DIANA-microT (Supplementary
Figure S10). The two spheres of influence seen in the DIANA-
microT network are also present in the TargetScan network. We also
see that the two spheres of influence are likewise organised around a
small number of central nodes, comprising the assorted clubs from
DIANA-microT. The different properties of the network (clustering
coefficient, centrality measurements, number of connected nodes, etc.)
are almost identical to those of DIANA-microT network (Supple-
mentary Figure S11). One major difference is the fact that the hubs
from the network are different, and as such, the assorted club 2 from
the DIANA-microT graph does not come out as an assorted club in
TargetScan. However, even though they are no longer hubs, they are
still very central to the network and globally still define two spheres of
influence (Supplementary Figure S10). The intermediate zone is less
obvious, even though the microRNAs from this zone are still mostly
located between the two spheres. Despite the fact that we observe
three-fold more microRNAs in the TargetScan network, 5 out of the
7 hubs with high betweenness centrality previously described in the
DIANA-microT network are found within the 30 first betweenness
centrality sorted nodes. The 5 microRNAs are, in decreasing order of
centrality: miR-548c-3p, miR-590-3p, miR-661, miR-186 and miR-
940. Lastly, 7 hubs from the 11 hubs discovered by DIANA-microT
are retrieved within the 40 degree sorted nodes on the TargetScan
network (in decreasing order by degree: miR-548c-3p, miR-590-3p,
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miR-579, miR-186, miR-513a-3p, miR-661, miR-495 and lastly miR-
940).
The 11 hubs identified by DIANA-microT were compared with
the two prediction algorithms. Interestingly, the two assorted clubs
are connected with density profiles that are almost identical in both
networks (Supplementary Figure S12a and b). This proves that the
connections between the microRNAs are robust across database
changes. A major difference is that the two clubs are now connected
in the TargetScan network. This connection is made via miR-548c-
3p (Supplementary Figure S12c). Importantly, when looking at gene
ontology enrichment for the two assorted clubs with TargetScan
predictions, the results are equivalent to DIANA-microT target onto-
logy enrichment (Supplementary Tables XII and XIII). Surprisingly,
even more significant P-values are observed for the targets predicted
by TargetScan for the assorted club 2 (typically by one order of
magnitude), again with a focus on GTPase signalling.
To conclude, even though the hubs are not the same between
different target prediction databases and despite all the differences
Figure 4 | Effect of miR-612, miR-661 and miR-940 on RPE1 migration and proliferation. (a) Motility graph: Normalised number of cells for the
transwell assay. RPE1 cells were independently transfected with mimics of miR-661, miR-612 and miR-940. The number of cells that passed through
the 5 mm holes after 18 hours were counted. Four independent experiments were conducted. The cell number was normalised based on the negative
control cells, and all four experiments were pooled. P-values were calculated using the non-parametric two sidedMann-Whitney test. (b)Wound healing
assay. Relative wound closure after a scratchwasmade in confluent cells transfected bymimics of the threemicroRNAs. The experimentwas conducted on
10 hours with images taken at t0, t015h, t017.5h, and t0110h. Each condition was present in triplicates. (c) Vinculin and phalloı¨din immunostaining
images of the cells transfected by mimics of the three microRNAs. The images were taken at the AxioImagerH.
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in target prediction, the relations (target sharing and, therefore, con-
nections) between the different microRNAs remain consistent, as do
the ontology prediction and the general shape of the networks.
Discussion
MicroRNAs are crucial entities that regulate diverse biological pro-
cesses in cells by targeting many different mRNAs. Furthermore,
many genes are targeted by at least a few microRNAs. Under these
two assumptions, systems biology seems to be the method of choice
to characterise the complementary role of microRNAs. Here, we
present a way to infer microRNA networks, taking into account
target similarities based on the principle that if twomicroRNAs share
similar targets, they may coregulate similar pathways. Tsang et al.
already suggested that microRNA cotargeting is prevalent in the cell
and considered microRNA families in their study46, where they
hypothesised that different microRNAs targeting the same genes
would imply a wider range of target-level modulation. In fact, two
microRNAs can also be functionally related if they regulate different
genes that reside in the same pathways, a question that was addressed
by Xu et al.6 when they developed an approach for microRNA net-
works based not only on target sharing but also on similarities in GO
biological processes. In our case, we sought to obtain information on
the processes that the group might coregulate rather than to use
ontology as a tool to infer networks. More importantly, we focused
our analysis on the role of hub microRNAs, i.e., microRNAs that are
more connected than others due to their high number of predicted
targets.
Although it is known that in silico predictions have a high per-
centage of false positives, we decided to keep every available predic-
tion in our analysis. With the sensitivity of microRNA target
prediction algorithms being approximately 66%47, some studies rely
solely on experimentally validated microRNA-gene interactions48.
However, even though these data may be considered more robust,
they are still very limited. For example, only one target is validated for
miR-612 in the latest miRTarBase release v4.549, and none of those in
miRecords v4 are validated50. Not only do the predictions have a high
false positive rate, but the coverage between different algorithms is
Figure 5 | Relative expression of miR-940 in breast cancer. Expression of miR-940 on three datasets of human breast cancer taken from GEO
(GSE38867, GSE44124 and GSE31309). The expression of themicroRNA is consistently downregulated in breast cancer tissues on the three experiments.
On two out of three microarray sets, miR-940 is differentially expressed with high significance based on limma analysis (p-Value , 0.001).
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also low (approximately 60% between TargetScan v6.2 and DIANA-
microT v3: Supplementary Figure S9). Regardless of the aforemen-
tioned issues, the networks built independently with the two algorithms
gave almost equivalent results, both in terms of network architecture
and in terms of hypotheses for the biological implications of the two
groups of interconnected hubs.
The interconnected hubs defined two spheres ofmicroRNAs sepa-
rated by an intermediate zone. A high correlation between the
enrichment of the assorted clubs and their respective spheres could
be observed, hence the name ‘‘sphere of influence’’. An important
idea in our analysis is the notion of global exploration, meaning that
even though the two spheres are mostly involved in their own
respective pathways, some microRNAs of the two zones might have
little or no involvement in the corresponding pathways. Keeping in
mind that we restricted our analysis to a global view of microRNA-
mediated biological regulation, we note the link between the structure
of the graph (two subnetworks with central hubs) and the biological
functions shared by many (but not all) microRNAs in each sphere of
influence.
The second central hub group, named ‘‘assorted club 2’’, was
composed of miR-612, miR-661 and miR-940. Very little has been
reported on the functional role of these microRNAs in human cells.
The analysis of GO among gene targets of the 3 microRNAs was
enriched in terms related to small GTPase-mediated signal transduc-
tion and, as a consequence, may show an involvement of the 3
microRNAs on the cytoskeleton and affect cell motility. We per-
formed functional validation experiments and confirmed that
mimics of each of these microRNAs were acting on the cytoskeleton
through phosphorylation of myosin II, a key molecular step in cytos-
keleton control. However, the introduction of the microRNAs into
RPE1 cells induced different phenotypic outcomes. Strikingly, the
ectopic expression of miR-661 strongly modified the spatial phos-
phorylation of myosin II, while in contrast, overexpression of either
miR-612 ormiR-940 inhibitedmyosin II phosphorylation (Figure 3).
This antagonistic phenotypic outcome was further confirmed by
invasion experiments (Figure 4). Together, these experimental valida-
tions confirmed the involvement of the assorted club 2 in the regu-
lation of small GTPase signalling, the actin cytoskeleton, cell motility
and cell invasion. Because the three microRNAs lead to different
phenotypic effects, it might be not surprising that these microRNAs
are not expressed at the same time in a tissue. Confirming this state-
ment, the three miRNAs were not found co-expressed in breast, pro-
state, colorectal mucosa, lung, blood, prefrontal cortex, liver and
muscle normal tissues. Therefore, it would have been difficult to infer
this network relying on the expression level of microRNAs. These data
further emphasise the relevance of the target-based microRNA net-
works that we have inferred.
To our knowledge, miR-940 had never been reported as differenti-
ally express in breast cancer. This absence might be explained by the
fact that miR-940 is never one of the most differentially expressed
microRNA in these datasets even though its expression trend is con-
sistent. Here, we demonstrated for the first time its capacity to modu-
late cell cytoskeleton and reduce RPE1 cell migration and invasion and
showed that its expression is reduced in breast cancer (Figure 5). Also
in agreement with our results, it was recently shown that miR-612
exerts an inhibitory effect on hepatocellular carcinoma, proliferation,
migration, invasion, and metastasis. Moreover, miR-612 appears to be
involved in both the initial and final steps of the metastatic cascade by
suppressing local invasion and distant colonization51. Similarly, our
results appear to be in agreement with reports from Vetter et al., who
have shown that miR-661 contributes to breast cancer cell invasion
through the targeting of Nectin-1 and StarD1052. Furthermore, we
demonstrated here that miR-612 and miR-661 also regulate cell mot-
ility via opposite effects on myosin II phosphorylation.
In the near future, we will further investigate the mechanism of
action of miR-661 with regard to the p53 status of the cells, as it was
recently reported that miR-661 may either suppress or promote
cancer aggressiveness, depending on the p53 status53.
Methods
Target prediction datasets. The flat file of DIANA-microT version 3.0 (July 2009)13
was downloaded from the web site http://diana.cslab.ece.ntua.gr/microT/. The
database consists of genome-wide computationally predicted associations between
microRNAs and their predicted targets in ensemble id format. Only Homo sapiens
gene-microRNA information was considered. Scores and multiple binding sites were
not taken into account (miTG score . 0), so that the lowest possible level of false
negative prediction was considered. Under this restriction, there are 555 microRNAs
that are predicted to regulate 18,986 different genes. The DIANA-microT dataset
comprised our main dataset for network building.
To compare the network outcome with that of another prediction algorithm,
TargetScan v6.2 non-conserved44 was downloaded from the web site http://www.
targetscan.org/vert_61/ (June 2012) (Date of access: 15/06/2013). Again, only Homo
sapiens gene–microRNA information were considered, which led to 1,531
microRNAs regulating 18,366 genes. No other criterion of selection was used.
Network building. Based on the idea that microRNAs that share the same targets
might act in the same pathways, a microRNA undirected weighted graph G5 (N, E)
was built, where each node N represents a microRNA and each edge E represents the
percentage of shared targets. To define the percentage of shared targets, the meet/min
index (or Simpson index) was used. The metric is highlighted in ref. 16 and can be
simply defined as:
meet=min
A,Bð Þ
~
A\B
min #A,#Bð Þ ð1Þ
where A and B represent the sets of genes regulated by microRNA A and microRNA
B, respectively, and # stands for the number of targets regulated by the corresponding
microRNA. The network built upon this metric is a densely connected network with
555 nodes and 153,735 weighted edges.
To analyse this dense weighted network, it was further simplified into a binary
network by defining ameet/min threshold under which edges betweenmicroRNAs in
the network were deleted. To do so, different graph properties were calculated and
compared for different meet/min thresholds. We calculated the clustering coefficient,
two different centrality measurements (degree and betweenness centrality), the
density, and the assortativity coefficient54. We defined the meet/min threshold as 0.5.
The final network comprised 555 nodes and 2,911 edges.
These microRNA graphs were also compared to 3 different graphs. The first graph
was a random graph based on the Erdo˝s-Re´nyi random graph construction algo-
rithm23, where each edge has the same probability of appearance during construction.
We considered for this construction 551 nodes and 2,911 edges, as for the meet/min
0.5 network. The second graph was a scale-free graph based on the Baraba´si-Albert
model24 considering 551 nodes; at the end of the construction, the network will have
scale-free properties as defined by Baraba´si and Albert. The final graph is a real
network of a human protein-protein interaction map based on yeast two-hybrid25.
The graphs were built using the package igraph55 from the R statistical envir-
onment56 and visualised using Cytoscape with the unweighted spring embedded
layout57.
Assorted club deciphering. First, the hubs of the network were sorted out according
to the degree of each node. We then looked at the induced subgraph formed by the ith
first sorted hubs (beginning with the first two hubs). Ultimately, 11 hubs were
considered, defining two ‘‘assorted clubs’’27: the first comprising 8 microRNAs, and
the second comprising 3microRNAs. The 12th hubwas isolated from the 11 first hubs.
Ontology enrichment calculation for microRNA clusters. The ontology
enrichments were calculated using the R package topGO30. All levels of gene ontology
(GO) were considered: biological process (BP), molecular function (MF) and cellular
component (CC). For BP terms, only those annotated for less than 5,000 genes and
more than 10 genes were considered. To calculate the enrichment, Ensembl ids were
used with DIANA-microT v3 predictions, and Entrez ids were used with TargetScan
v6. All genes predicted by the respective algorithms were used as background genes
for the two enrichment analyses. The ontology enrichment in terms of biological
processes, molecular function and cellular component categories was built on genes
that were shared by at least 50% of the group of microRNAs (e.g., for a cluster of 3
microRNAs, a gene must be predicted to be regulated by at least 2 microRNAs to be
considered). For the spheres of influence, a lower threshold of 25% was also used to
reduce the restriction on the shared genes.
A classic Fisher’s exact test was considered for the enrichment analysis. P-values
were adjusted using the Benjamini and Hochberg correction29, and all enriched
annotations obtained for each level of GOwere used in themultiple testing step (4,109
in BP, 1,277 in CC, and 3,732 in MF with DIANA-microT background genes). The
corrected P-values were considered significant when , 0.05, although we did not
consider this criteria as a strict decision-making threshold. The reader can refer to
other publications for a discussion58,59. Briefly, multiple testing procedures generally
suppose that all tested hypotheses are independent. In the case of GO enrichment, the
structure of the tree involves dependences among the different annotations, which
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make the BH correction too stringent in this case. We thus also considered the
annotations with less significant corrected P-values.
Cell culture and transfection. Human telomerase-immortalised Retinal Pigmented
Epithelial cells (hTERT-RPE1 or RPE1, Takara Bio Inc., Kyoto, Japan) were grown at
37uC and 5% CO2 in DMEM/F12 (Invitrogen, Carlsbad, California) supplemented
with 10% fetal calf serum, 2 mM glutamine, 100 U/ml penicillin and 100 U/ml
streptomycin. Reverse transfection was performed using lipofectamine RNAiMax
(Invitrogen, Carlsbad, California) for 48 h. The final concentration of microRNA
mimic and siRNA was 20 nM. The microRNAmimics (miR-612, miR-940 and miR-
661) were purchased from Thermo Scientific (Waltham, Massachusetts) Dharmacon
(miRIDIAN). The siRNA sequence AllStars scramble (Qiagen, Venio, The
Netherlands) was used as a negative control, and ROCK inhibitor Y27632 (refY0503:
Sigma-Aldrich, St. Louis, Missouri) was used as a positive control. Y27632 was added
at 10 mM for the last 24 h.
Cell lysis, protein extraction, and Western blotting. Protein lysates were prepared
in ice-cold RIPA (Thermo Scientific), supplemented with protease cocktail inhibitor
(complete mini; Roche, Basel, Switzerland), 1 mM PMSF, 2 mM Na3VO4, and
glycerophosphate. Homogenates were cleared by centrifugation at 15,000 g for
15 min at 4uC. A total of 10 mg of proteins were run on SDS-polyacrylamide gels and
blotted onto nitrocellulose membranes. Blots were blocked in 3% BSA (in TBST) for
1 h and then incubated with the primary polyclonal rabbit antibody against
phosphomyosin light chain 2 (1:1000; Cell Signaling Technology, Danvers,
Massachusetts) in 3% BSA overnight at 4uC. Visualisation was performed using a
horseradish peroxidase-conjugated antibody (anti-rabbit; Santa Cruz Biotechnology,
Dallas, Texas). For the loading control, a GAPDH rabbit polyclonal antibody was
used.
Micropatterning. Glass coverslips were first spin coated at 3,000 rpm for 30 s with
an adhesion promoter (TI Prime; MicroChemicals, Madhya Pradesh, India) and then
with 0.5% polystyrene dissolved in toluene. The polystyrene layer was further
oxidised with an oxygen plasma treatment (FEMTO; Diener Electronics, Germany)
for 10 s at 30 W and incubated with 0.1 mg/ml polylysine polyethylene-glycol
(JenKem Technology, Beijing, China) in 10 mMHepes, pH 7.4, at room temperature
for 1 h. Coverslips were then dried by spontaneous dewetting. Polyethylene-glycol–
coated slides were placed in contact with an optical mask holding the transparent
micropatterns (Toppan Photomasks, Round Rock, Texas) using a home-made
vacuum chamber and exposed for 5 min to deep UV light (UVO Cleaner; Jelight
Company, Irvine, California). Micropatterned slides were washed once in PBS and
finally incubated for 30 min with a solution of 50 mg/ml bovine fibronectine solution
(Sigma-Aldrich, St. Louis, Missouri) and 5 mg/ml Alexa Fluor 646– or Alexa Fluor
542–labelled fibrinogen (Invitrogen, Carlsbad, California). Before plating cells,
patterned coverslips were washed three times with sterilised PBS. The small circular
fibronectine micropattern has a size of 500 mm2, and the large circular fibronectine
micropattern is 1000 mm2.
Immunostaining. RPE1 cells were transfected with AllStars siRNA or mimics of
miR-612, miR-661 or miR-940 at 20 nM for 48 h. The positive control (Y27632) was
added to the siRNA AllStars-transfected cells at 10 mM for the last 24 h. The
transfected cells were then plated on the micropatterns.
After cell adhesion onto the micropatterns (2 h), RPE1 cells were pre-permeabi-
lized for 15 seconds with 0.1% Triton X-100 in cytoskeleton buffer pH 6.1 and fixed in
4% paraformaldehyde in cytoskeleton buffer for 15 min at room temperature. They
were then rinsed twice with PBS and incubated in 0.1 M ammonium chloride in PBS
for 10 min. Cells were then blocked with 3% BSA in PBSCa21 Mg21 for 30 min.
Images were taken with an upright microscope (BX61; Olympus, Tokyo, Japan).
Fluorescent images of myosin and actin staining are maximal projections of different
aligned cells acquired with oil immersion objectives at 1003 (NA5 1.4) mounted on
a piezo ceramic (Physics Instruments, Lederhosen, Germany). Five individual and
typically representative images can be found in Supplementary Figure S13. The
microscope was controlled withMetamorph software (MDSAnalytical Technologies,
Toronto, Canada). The images were processed using ImageJ software60. To measure
the intensity of myosin and actin fluorescence, individual cells were first segmented,
and the integrated density of fluorescence was calculated on the segmented cells for
both phosphomyosin and actin. The segmentation was performed as follows: a
median filter with a radius of 15 pixels was applied on the FITC channel images
(phalloidin-stained images), followed by an auto-thresholding using the ‘‘Li’’ method.
For the unrestricted cell images, the cells were transfected in an 8wells withmimics
of the siRNA as previously described. Vinculin and phalloidine staining were used
and images were taken at the AxioImagerH (ZEISS, Oberkochen).
Transwell assay.RPE1 cells were seeded in six-well microtiter plates, cultured for one
day, and then transfected with mimics of miR-612, miR-661, or miR-940 or with a
negative control siRNA (siRNA AllStars) at a final concentration of 20 nM. Twenty-
four hours after transfection, cells were trypsinized, re-suspended in culture medium
without fetal bovine serum (0% FBS) and counted using a ScepterTM 2.0 (Merck
Millipore, Billerica, Massachusetts). A similar cell number was then dispensed on the
TranswellH inserts (Corning, polycarbonate membrane, 5.0 mm pore size), and cell
migration was induced by the presence of complete culture medium containing
serum (10% FBS) in the lower compartments. After 18 hours, cell migration was
stopped, and cells were washed (PBSCa21 Mg21), fixed (PFA 4%) and permeabilized
(100% methanol). For cell counting, cell nuclei were stained with Hoechst 33342,
and cells from the deposition side (upper compartment) were removed with a
cotton swab. Images of the lower side of the insert were captured (10 different
fields of view per insert) with an epifluorescence microscope (Imager Z1 from
Zeiss, Oberkochen, Germany) using AxioVision software with a 10-fold objective
(Plan-Neofluar 10x/0.30). The quantification of the number of cells that reached
the lower side of the insert was performed either semi-automatically using ImageJ
software60 or manually.
Four independent experiments with varying initial numbers of deposited cells (to
better emphasise either the increase or decrease in the number of cells passing
through the holes) were conducted. Each condition (miR-612, miR-661, miR-940,
and siRNA-AllStars) was represented in triplicate, leading to 30 observations per
experiment and per condition (Supplementary Figure S14). To pool the four
experiments together, each condition of each experiment was normalised to the
median number of cells in the siRNA-AllStars condition (mediansiRNA{AllStarsx ),
considering all replicates:
~Nx,y,t~log10
Nx,r,t
mediansiRNA{AllStarsx
 
ð2Þ
where N is the number of counted cells and N˜ the normalised number of cells for each
condition, replicate and experiment; x is the experiment (1, 2, 3 or 4), r, the replicate
for each experiment (1, 2 or 3), and, the different conditions (siRNA-AllStars or
mimics of miR-612, miR-661 or miR-940). N˜ is thus normalised at 0 for siRNA-
AllStars. P-values were then calculated using the non-parametric two-sided Mann-
Whitney test (Wilcoxon test) available in R statistical software.
Wound healing assay. RPE1 cells were deposited into a transparent-bottomed 96-
well microtiter plate with DMEM medium in presence of 10% FBS and without any
antibiotics. After 24 h, the RPE1 cells were transfected either with siAllStars or the 3
microRNAs at 20 nM in triplicates. 48 hours after transfection, 500 mm-large
wounds with low width variability were produced in every confluent cell cultures
using a wound replicator equipped with 96 pins (V&P Scientific, San Diego,
California). The wounds were immediately imaged as well as 5 h, 7.5 h and 10 h after
wound formation. No image was taken 2.5 h after wound formation in order to let the
cells recover frommechanical and thermal stress resulting from the process of wound
formation.
At every time point, the images of the wounds were acquired at 8 exposure times
using parallelised holographic microscopy, i.e., an array of 96 Complementary Metal
Oxide Semiconductor (CMOS) image sensors (STMicroelectronics, Grenoble,
France) placed under the 96-well microtiter plate61. Holographicmicroscopy relies on
the digital recording of the diffraction patterns (i.e., holograms) made by the cells
under coherent illumination. The 8 images taken at various exposure times for every
time point were combined to produce a contrasted, non-saturated image using aHigh
Dynamic Range (HDR) approach. The edges of the wound were automatically
detected on the HDR images by a k-means/Markov random field process and a
parallel double snake62. Results of automated wound segmentations were validated by
eye. Evolution of the average width of thewounds was finally normalised in relation to
the initial wound width and pooled for every transfection condition.
Expression data. To assess for microRNA expression in different tissues,
samples from 8 different normal tissues were downloaded from GEO. The 8
downloaded datasets comprised GSE19505 (Prefrontal cortex and liver),
GSE23527 (Skeletal muscle), GSE24205 (Blood), GSE25508 (Lung), GSE31309
(Breast), GSE34933 (Prostate), and GSE38309 (Colorectal mucosa). The raw
data were downloaded and extracted from GEO. Datasets showing negative
numbers were adjusted by adding a constant such that the minimum observed
value was equal to 1 and then log2 transformed. Finally, a quantile
normalization was applied68. Cytoscape was used with the DIANA-microT
network to visualize microRNA expression levels for each dataset separately.
Represented on the networks is the median value of each microRNA expression
in control tissues. Min and max observed expression on each dataset were used
to define the legend limits with a continuous gradation from white to red. The
white limit was set as the median expression on each dataset so that not all
nodes would be highlighted. As a consequence, only microRNAs with
expression 50% over all miRNA expression(s) in a dataset (moderately to highly
expressed on a chip) are coloured. Differences in colour spreading thus reflect
the difference in expression score distribution across datasets (Supplementary
Figure S15).
For the differential expression analysis, the raw data of the three breast cancer
microRNA expression datasets were retrieved onGene Expression Omnibus (GEO)63
under the ID GSE31309, GSE38867 and GSE44124. Only datasets with at least 20
samples were considered. As such, GSE31309 comprises 105 samples with 57 healthy
controls. GSE38867 is composed of 28 samples with 7 normal tissues, and finally
GSE44124 is built of 53 samples with 3 pools of normal tissue. All data were log2
transformed and quantile normalised64 using either affyPLM package65 or
AgiMicroRna package66 in R, depending on the data type. After data normalisation,
the package Limma67 was used to calculate P-values for differential expression ofmiR-
940 in breast cancer tissues against normal tissues. As we investigated only one
microRNA per dataset, no correction for multiple testing was applied.
All calculations in this paper were conducted in the statistical environment R56.
Box-and-whisker plots show the lower and upper quartiles (25–75%) with a line at the
www.nature.com/scientificreports
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median.Whiskers extend to 1.5 times the interquartile range (defined as quartile 75%
– quartile 25%). The circles show data outside the whiskers (‘‘outliers’’).
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